How to buy Botanix Pharmaceuticals (BOT) shares

Learn how to easily invest in Botanix Pharmaceuticals shares.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Botanix Pharmaceuticals is a biotechnology business based in Australia. Botanix Pharmaceuticals shares (BOT) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Botanix Pharmaceuticals has a market cap (total outstanding shares value) of $76.9 million. If you're looking to buy shares, check out the steps below.

How to buy shares in Botanix Pharmaceuticals

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Botanix Pharmaceuticals. Find the share by name or ticker symbol: BOT. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Botanix Pharmaceuticals reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check on your investment. Congratulations, you own a part of Botanix Pharmaceuticals. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.

Botanix Pharmaceuticals stock price (ASX:BOT)

Use our graph to track the performance of BOT stocks over time.

Botanix Pharmaceuticals shares at a glance

Information last updated 2022-05-15.
52-week range$0.053 - $0.099
50-day moving average $0.0758
200-day moving average $0.0675
Target priceN/A
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.011

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 9 of 9
Name Product Standard brokerage fee Inactivity fee Markets
ThinkMarkets Share Trading
$8
No
ASX shares
Exclusive: Sign up through Finder and get 3 months of free trading up to 50 trades. Offer available to new customers only.
Following your first three months, enjoy $8 flat fee CHESS sponsored brokerage as well as free live stock data all from the convenience of an easy-to-use mobile app
Tiger Brokers
Exclusive
Tiger Brokers
$6.49
No
ASX shares, Global shares, US shares
Exclusive to Finder: Sign up to Tiger through Finder and on completion of your first deposit of any amount or transfer of shares receive 1 extra free GoPro share. T&Cs apply.
Get started with $0 brokerage on ASX and US stocks for the first 3 months upon completion of your first qualifying deposit. Also receive a free Apple share if you deposit $3,000 or more.
SelfWealth (Basic account)
$9.5
No
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
IG Share Trading
$8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
CMC Markets Invest
$0
No
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges. Plus, buy Aussie shares for $0 brokerage up to $1,000. (Limited to one buy order per stock per trading day).
Superhero share trading
$5
No
ASX shares, US shares, ETFs
Sign up & fund your account with A$100 or more and receive US$10 of Tesla stocks on Superhero. T&Cs apply.
Enjoy $0 brokerage on US stocks and buying ETFs as well as a flat $5 fee to trade Australian shares.
GO Markets Share Trading
$7.70
No
ASX shares, Forex, CFDs, ETFs
Zero Brokerage on your next 50 trades!
Simply transfer an existing HIN before 30 June and pay no fees on your next 50 transactions. Alternatively, transfer your existing shares and receive 5 transactions at zero cost for each shareholding transferred, once again up to 50 free trades. T & Cs apply
Saxo Capital Markets (Classic account)
$5
No
ASX shares, Global shares, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
Bell Direct Share Trading
$15
No
ASX shares, mFunds, ETFs
Get $300 free brokerage until 30 June when you move to Bell Direct. T&Cs apply.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
loading

Compare up to 4 providers

Is it a good time to buy Botanix Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Botanix Pharmaceuticals price performance over time

Historical closes compared with the last close of A$0.075

1 week (2022-05-12) 15.38%
1 month (2022-04-19) -9.64%
3 months (2022-02-18) 29.31%
6 months (2021-11-19) 25.00%
1 year (2021-05-19) 2.74%
2 years (2020-05-19) 74.42%
3 years (2019-05-17) -34.78%
5 years (2017-05-19) 50.00%

Botanix Pharmaceuticals financials

Operating margin TTM 5603232%
Gross profit TTM $315,799
Return on assets TTM -29.9%
Return on equity TTM -53.53%
Profit margin 0%
Book value 0.015
Market capitalisation $76.9 million

TTM: trailing 12 months

Botanix Pharmaceuticals share dividends

We're not expecting Botanix Pharmaceuticals to pay a dividend over the next 12 months.

Have Botanix Pharmaceuticals's shares ever split?

Botanix Pharmaceuticals's shares were split on a 1:3 basis on 15 June 2016. So if you had owned 3 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Botanix Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Botanix Pharmaceuticals shares which in turn could have impacted Botanix Pharmaceuticals's share price.

Botanix Pharmaceuticals share price volatility

Over the last 12 months, Botanix Pharmaceuticals's shares have ranged in value from as little as $0.053 up to $0.099. A popular way to gauge a stock's volatility is its "beta".

BOT.AU volatility(beta: 2.4)Avg. volatility(beta: 1.00)LowHigh

Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Botanix Pharmaceuticals's is 2.396. This would suggest that Botanix Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Botanix Pharmaceuticals overview

Botanix Pharmaceuticals Limited, a clinical stage synthetic cannabinoid pharmaceutical company, engages in the research and development of dermatology and antimicrobial products in Australia. Its product pipeline include BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIa clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase Ib clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in North Perth, Australia.

Botanix Pharmaceuticals in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site